Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-01

Clinical Trial Update: Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.

View source ↗

Summary

This clinical trial update describes the Antiretroviral Pregnancy Registry (APR), a multi-sponsor effort to monitor for major teratogenic effects from antiretro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Syneos Health | Conditions: HIV Infections, Hepatitis B | Status: RECRUITING